Business Context and Reporting Period
Company: Merit Medical Systems, Inc. (MMSI)
Filing Type: Form 8-K (Current Report)
Date of Report: July 30, 2026
Reporting Period: Second Quarter ended June 30, 2026
This filing announces the issuance of a press release and conference call presentation regarding the company's operating and financial results for the quarter ended June 30, 2026, and includes an update to full-year 2026 guidance.
Key Financial Metrics
The provided text serves as a cover report referencing attached exhibits (Exhibit 99.1 and 99.2) for specific data. The filing text itself does not contain numerical values for the following metrics:
- Revenue: Not stated in text (referenced in attached press release).
- Profit and Margins: Not stated in text.
- Cash Flow: Not stated in text.
- Debt and Liquidity: Not stated in text.
The company discloses both GAAP and non-GAAP financial information in the attached exhibits, including reconciliations between the two measures.
Material Changes and Guidance
Guidance Update: The company has updated its full-year 2026 guidance, as detailed in the attached press release (Exhibit 99.1).
Limitations on Forward-Looking Information: Merit Medical explicitly states it does not provide guidance for GAAP reported financial measures (other than revenue) or a reconciliation of forward-looking non-GAAP measures to GAAP measures. This is due to the inability to predict with reasonable certainty the financial impact of:
- Acquisition-related expenses.
- Non-cash expenses (amortization/write-offs of assets).
- Severance and performance-based stock compensation.
- Litigation, administrative proceedings, and settlements.
- Changes in governmental or industry regulations.
Management notes that including these uncertain items in GAAP reconciliations could be confusing to investors or cause undue reliance.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q2 2026 revenue, earnings, and margin figures.
- Examine the full-year 2026 guidance update details within the press release.
- Analyze the non-GAAP to GAAP reconciliations provided in the exhibits to understand the impact of excluded items.
- Verify the conference call presentation (Exhibit 99.2) for management commentary on operational drivers and risks.
- Monitor for updates on litigation and regulatory changes cited as key uncertainties affecting future GAAP results.